Key result
Rapid ventricular pacing in canines progressively reduced stroke volume to 49.6% of baseline at 1 month, with synthetic flow indices showing high concordance with measured flow.
Why the study?
Pulsatile hemodynamics analyses provide information on the ventricular-arterial system unavailable from standard blood pressure measurements, but have limited preclinical applications.
Absolute Event Rate: 49.6% vs 100%
p-value: p=0.001
Computational models synthesizing flow from pressure waveforms can accurately assess pulsatile hemodynamics in a preclinical canine heart failure model, offering a less invasive alternative to directly measured flow.
Supports synthetic flow indices for characterizing HF progression in canine models; leaves open translation to clinical hemodynamic assessment.
Pulsatile hemodynamics analyses provide important information about the ventricular-arterial system which cannot be inferred by standard blood pressure measurements. Pulse wave analysis (PWA), wave separation analysis (WSA), and wave power analysis (WPA) characterize arterial hemodynamics with limited preclinical applications. Integrating these tools into preclinical testing may enhance understanding of disease or therapeutic effects on cardiovascular function. We used a canine rapid ventricular pacing (RVP) heart failure model to: (1) Characterize hemodynamics in response to RVP and (2) assess analyses from flow waveforms synthesized from pressure compared to those derived from measured flow. Female canines (n = 7) were instrumented with thoracic aortic pressure transducers, ventricular pacing leads, and an ascending aortic flow probe. Data were collected at baseline, 1 week, and 1 month after RVP onset. RVP progressively reduced stroke volume (SV), the PWA SV estimator, and WSA and WPA pulsatility and wave reflection indices. Indices derived from synthesized flow exhibited similar directional changes and high concordance with measured flow calculations. Our data demonstrate the value of analytical hemodynamic methods to gain deeper insight into cardiovascular function in preclinical models. These approaches can provide complementary value to standard endpoints in evaluating potential effects of pharmaceutical agents intended for human use.
No takes yet. Share an insight, caveat, or question.
Hotek et al. (2023) studied Heart failure (n=7). Rapid ventricular pacing (RVP) vs. Baseline was evaluated on Stroke volume (SV) as percent of baseline at 1 month (p=0.001). Rapid ventricular pacing in canines progressively reduced stroke volume to 49.6% of baseline at 1 month, with synthetic flow indices showing high concordance with measured flow.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: